Characterization of neutralizing epitopes of varicella-zoster virus glycoprotein H

Journal of Virology

Volumn 83, Issue 4, 2009, Pages 2020-2024

  Akahori, Yasushi ^a   Suzuki, Kazuhiro ^a,b   Daikoku, Tohru ^c   Iwai, Masae ^c   Yoshida, Yoshihiro ^c   Asano, Yoshizo ^d   Kurosawa, Yoshikazu ^a   Shiraki, Kimiyasu ^c  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b Institute for Antibodies Ltd   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

^d FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; EPITOPE; HUMAN MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS GLYCOPROTEIN H;

ARTICLE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DETERMINATION; VARICELLA ZOSTER VIRUS; VIRUS ENTRY; VIRUS INFECTION; VIRUS NEUTRALIZATION;

ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; EPITOPE MAPPING; EPITOPES; HERPESVIRUS 3, HUMAN; HUMANS; MEMBRANE GLYCOPROTEINS; NEUTRALIZATION TESTS; VIRAL PROTEINS;

HUMAN HERPESVIRUS 3;

EID: 59649108574     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02097-08     Document Type: Article

References (23)

1. Cole, N. L., and C. Grose. 2003. Membrane fusion mediated by herpesvirus glycoproteins: the paradigm of varicella-zoster virus. Rev. Med. Virol. 13:207-222.
2. Drew, P. D., M. T. Moss, T. J. Pasieka, C. Grose, W. J. Harris, and A. J. Porter. 2001. Multimeric humanized varicella-zoster virus antibody fragments to gH neutralize virus while monomeric fragments do not. J. Gen. Virol. 82:1959-1963.
3. Duus, K. M., C. Hatfield, and C. Grose. 1995. Cell surface expression and fusion by the varicella-zoster virus gH:gL glycoprotein complex: analysis by laser scanning confocal microscopy. Virology 210:429-440.
4. Forghani, B., L. Ni, and C. Grose. 1994. Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein complex. Virology 199:458-462.
5. Grose, C., D. P. Edwards, W. E. Friedrichs, K. A. Weigle, and W. L. McGuire. 1983. Monoclonal antibodies against three major glycoproteins of varicella-zoster virus. Infect. Immun. 40:381-388.
6. Higo-Moriguchi, K., Y. Akahori, Y. Iba, Y. Kurosawa, and K. Taniguchi. 2004. Isolation of human monoclonal antibodies that neutralize human rotavirus. J. Virol. 78:3325-3332.
7. Keller, P. M., B. J. Neff, and R. W. Ellis. 1984. Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes. J. Virol. 52:293-297.
8. Matsui, S., T. Okuno, and K. Shiraki. 1994. Functional roles of terminal glycomoieties in varicella-zoster virus infection. Virology 198:50-58.
9. Montalvo, E. A., and C. Grose. 1986. Neutralization epitope of varicella zoster virus on native viral glycoprotein gp118 (VZV glycoprotein gpIII). Virology 149:230-241.
10. Pasieka, T. J., L. Maresova, and C. Grose. 2003. A functional YNKI motif in the short cytoplasmic tail of varicella-zoster virus glycoprotein gH mediates clathrin-dependent and antibody-independent endocytosis. J. Virol. 77:4191-4204.
11. Pasieka, T. J., L. Maresova, K. Shiraki, and C. Grose. 2004. Regulation of varicella-zoster virus-induced cell-to-cell fusion by the endocytosis-competent glycoproteins gH and gE. J. Virol. 78:2884-2896.
12. Rodriguez, J. E., T. Moninger, and C. Grose. 1993. Entry and egress of varicella virus blocked by same anti-gH monoclonal antibody. Virology 196:840-844.
13. Shiraki, K., Y. Hayakawa, H. Mori, J. Namazue, A. Takamizawa, I. Yoshida, K. Yamanishi, and M. Takahashi. 1991. Development of immunogenic recombinant Oka varicella vaccine expressing hepatitis B virus surface antigen. J. Gen. Virol. 72:1393-1399.
14. Shiraki, K., T. Okuno, K. Yamanishi, and M. Takahashi. 1982. Polypeptides of varicella-zoster virus (VZV) and immunological relationship of VZV and herpes simplex virus (HSV). J. Gen. Virol. 61:255-269.
15. Shiraki, K., H. Sato, J. Yamamura, Z. H. Li, T. Yokoyama, T. Hasegawa, T. Okuno, M. Kurokawa, and S. Kageyama. 1997. Functions of purified gB, gE:gI, and gH:gL, and their sialyl residues in varicella-zoster virus infection. Arch. Virol. 142:2295-2301.
16. Shiraki, K., and M. Takahashi. 1982. Virus particles and glycoprotein excreted from cultured cells infected with varicella-zoster virus (VZV). J. Gen. Virol. 61:271-275.
17. Shiraki, K., Y. Yoshida, Y. Asano, K. Yamanishi, and M. Takahashi. 2003. Pathogenetic tropism of varicella-zoster virus to primary human hepatocytes and attenuating tropism of Oka varicella vaccine strain to neonatal dermal fibroblasts. J. Infect. Dis. 188:1875-1877.
18. Sugano, T., T. Tomiyama, Y. Matsumoto, S. Sasaki, T. Kimura, B. Forghani, and Y. Masuho. 1991. A human monoclonal antibody against varicella-zoster virus glycoprotein III. J. Gen. Virol. 72:2065-2073.
19. Suzuki, K., Y. Akahori, Y. Asano, Y. Kurosawa, and K. Shiraki. 2007. Isolation of therapeutic human monoclonal antibodies for varicella-zoster virus and the effect of light chains on the neutralizing activity. J. Med. Virol. 79:852-862.
20. Taketa, K., K. Kamakura, S. Satomura, and H. Taga. 1998. Lectin-dependent modulation of interaction between human alpha-fetoprotein and its monoclonal antibodies. Epitope mapping. Tumour Biol. 19:318-328.
21. Tilley, S. A., W. J. Honnen, M. E. Racho, T. C. Chou, and A. Pinter. 1992. Synergistic neutralization of HIV-1 by human monoclonal antibodies against the V3 loop and the CD4-binding site of gp120. AIDS Res. Hum. Retrovir. 8:461-467.
22. Vijh-Warrier, S., A. Pinter, W. J. Honnen, and S. A. Tilley. 1996. Synergistic neutralization of human immunodeficiency virus type 1 by a chimpanzee monoclonal antibody against the V2 domain of gp120 in combination with monoclonal antibodies against the V3 loop and the CD4-binding site. J. Virol. 70:4466-4473.
23. Yokoyama, T., S. Ayabe, H. Miyagi, T. Sugano, A. Otsu, H. Sato, S. Kageyama, T. Fujii, and K. Shiraki. 2001. Varicella-zoster virus gH:gL contains a structure reactive with the anti-human gamma chain of IgG near the glycosylation site. J. Gen. Virol. 82:331-334.